Eating mangoes may hold potential in preventing metabolic disorders and diabetes, according to four separate studies presented at the 2017 Experimental Biology Conference.
In one of the studies, a team of researchers at the Texas A&M University’s Department of Nutrition and Food Science examined how lean and obese individuals absorbed, metabolized, and excreted gallic acid, galloyl glycosides, and gallotannin following mango consumption for six weeks. According to the researchers, eating mangoes for an extended period can increase the fruit’s anti-inflammatory effects compared with irregular consumption.
In another randomized study, health experts from the same university assessed how mango consumption affects the gut microbiota in both lean and obese individuals. The research team also investigated the fruit’s potential in containing galloyl metabolites and anti-inflammatory activities. It affirmed that galloyl-derivatives from mango may contain therapeutic potential in addressing obesity and metabolic disorder. However, the experts noted that larger-scale studies are warranted to confirm the findings.
In yet another study from the same university, a team of scientists evaluated the metabolic effects of daily mango consumption for six weeks among lean and obese participants. The researchers noted that eating mangoes daily during study period helped reduce blood pressure levels in lean participants. They also found that daily consumption helped obese participants maintain long-term glucose homeostasis. (Related: Mango, the new diabetes and cancer buster)
On the other hand, a study carried out by researchers at the Oklahoma State University assessed the post-prandial responses of otherwise healthy men after eating a high-fat breakfast with or without a mango shake. The experts found that drinking the mango shake made a modest difference in the participants’ post-meal response.
Previous study supports mangoes’ potential in diabetes management